Clinical Trials
49 trialsOvAR-Y
Washington University School of Medicine
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Alliance for Clinical Trials in Oncology
iCaRe2
University of Nebraska
Evaluation for NCI Surgery Branch Clinical Research Protocols
National Institutes of Health Clinical Center (CC)
DP-04
AstraZeneca
ELEPHAS-02
Elephas
CER
Cancer Support Community, Research and Training Institute, Philadelphia
TraveraRTGx
Travera Inc
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
ORI-EGI-03
Origin Sciences
MOMENTUM
UMC Utrecht
CAMPERR
Adela, Inc
ELEPHAS-05
Elephas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-Irradiation
University of Texas Southwestern Medical Center
ORACLE
Guardant Health, Inc.
DELFI-L101
Delfi Diagnostics Inc.
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
Genomic Testing and Resulting Medical Decisions
Arbeitsgemeinschaft medikamentoese Tumortherapie
PREVAILctDNA
Royal Marsden NHS Foundation Trust
INSPIRE
Singlera Genomics Inc.
ROOT
Taproot Health
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
SkinHealth
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
MARIA
Invitae Corporation
Patient-Derived Xenografts to Reduce Cancer Health Disparities
University of California, Davis
CINECI
University Hospital, Tours
IFACT
Memorial Sloan Kettering Cancer Center
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
Wuhan Ammunition Life-tech Co., Ltd
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Exact Sciences Corporation
PASSION
Assistance Publique - Hôpitaux de Paris
A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.
TScan Therapeutics, Inc.
PIONEER
SpeciCare
NIRPA
Gary Onik MD
E-MOSAIC Electronic Tool to Monitor Symptoms
Swiss Cancer Institute
N1
CureOne
Circulating Tumor DNA Exposure in Peripheral Blood
Quantgene Inc.
Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial
National Institutes of Health Clinical Center (CC)
Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871
Alliance for Clinical Trials in Oncology
Cancer in Patients With Gabapentin (GPRD)
GlaxoSmithKline
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
Wake Forest University Health Sciences
The Efficacy and Safety of Electronic Cigarettes: a 5-year Follow-up Study
Università degli Studi 'G. d'Annunzio' Chieti e Pescara
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Amgen
Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy
M.D. Anderson Cancer Center
Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and Survivors
National Institutes of Health Clinical Center (CC)
Cone Beam CT Scanning in Lung and Bladder Cancer.
AHS Cancer Control Alberta
OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer
OHSU Knight Cancer Institute
Monitor-GCSF
Sandoz
The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel
Meir Medical Center